Fact CheckerSign in

NCT06399952Recruiting

Baker Gordon Syndrome Natural History Study

A Prospective, Longitudinal and Observational Natural History Study for Children and Adults With Baker Gordon Syndrome - Genetic Autism Alliance

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
1 May 2024
Start date
30 Apr 2024
Primary completion date
5 May 2027
Lead sponsor
University of Missouri-Columbia
Diseases
Epilepsy, Autism
NCT number
NCT06399952

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 30 Apr 2024 to the primary completion date, 5 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The presence of another condition or co-morbidity unrelated to Baker Gordon syndrome, that affects neurodevelopment.
    • In this study, the primary caregivers/LAR for each participant diagnosed Baker Gordon Syndrome will be also considered participants.
    • Caregivers/LAR will have to meet the following inclusion criteria:
  • Legal caregiver of the patient diagnosed with a Baker Gordon Syndrome.

Age

  • \>18 years.
  • Less than 18 years old.

Other

  • Willingness to follow study procedures, as assessed by the research team.
  • Willingness to sign the consent form.
  • Ability to understand all the information regarding the study, as assessed by the research team.
    • Caregivers/LAR Exclusion Criteria:

Who the study is looking for

  • Genetically confirmed diagnosis of Baker Gordon syndrome.
  • 0-99 years
  • Ability to send medical records and diagnostic test results.
  • Ability to complete tests and questionnaires.

Age in the registry: 0 years to 99 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Missouri - Columbia
Coordinator of this site? Confirm its status
ColumbiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.